InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.55
(
0.70%
)
US TECH 100
18,328.20
(
1.00%
)
Dow Jones
39,103.46
(
0.10%
)
Brent Oil
81.98
(
0.82%
)
Bitcoin
68,952.03
(
1.51%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: None

Saturday, 07/26/2014 9:25:45 AM

Saturday, July 26, 2014 9:25:45 AM

Post# of 80490
This is an on-going story in the industry.

http://www.fool.com/investing/general/2014/07/24/pfizers-incoming-patent-cliff.aspx

Pfizer is not the only BP looking at quickly diminishing revenues. They are hungry for pipeline... and, of course Ariad certainly has pipeline.

This is why Yellen has no idea what she is talking about. Biotech is still very undervalued and I predict the pace of buyouts and mergers will increase substantially in the next year or two.

If I need advice on interest rates, I'll look to Yellen. Biotechs, not so much.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up